April 24, 2024

U.S. Over the Counter (OTC) Drugs Market Size, Growth Report by 2033

The U.S. over the counter (OTC) drugs market size was estimated to be around US$ 23.03 billion in 2023 and is projected to reach US$ 41.72 billion by 2033, indicating a CAGR of 6.42% from 2024 to 2033.

Key Points

  • By product type, the cough & cold products segment held the largest share of the market in 2023, the segment is observed to witness a notable growth during the forecast period.
  • By dosage form, the tablets segment dominated the market with the largest share in 2023.
  • By route of administration, the oral segment held the largest share of the market and is expected to sustain the position throughout the forecast period.
  • By distribution channel, the drug stores & retail pharmacies segment dominated the U.S. over the counter (OTC) drugs market in 2023.

U.S. Over the Counter (OTC) Drugs Market Size 2024 to 2033

The market research report on the U.S. over the counter (OTC) drugs market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of U.S. over the counter (OTC) drugs products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.

Get a Sample: https://www.precedenceresearch.com/sample/3753

U.S. Over the Counter (OTC) Drugs Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 6.42%
U.S. Market Size in 2023 USD 23.03 Billion
U.S. Market Size by 2033 USD 41.72 Billion
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Product Type, By Dosage Form, By Route of Administration, and By Distribution Channel

Read More: Artificial Intelligence Engineering Market Size, Growth Report by 2033

The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.

Focusing on the global U.S. over the counter (OTC) drugs market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the U.S. over the counter (OTC) drugs market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.

Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of U.S. over the counter (OTC) drugs products across different countries and applications.

Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.

The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.

This in-depth research report offers valuable insights into the U.S. over the counter (OTC) drugs market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.

The competitive landscape section of the report provides detailed information on xx market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the U.S. over the counter (OTC) drugs market.

Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report

Reasons to Purchase this Report:

  • Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
  • In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
  • Market size in USD million and volume in million units provided for each segment and sub-segment.
  • Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
  • Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Key Market Players

  • Bayer AG
  • Takeda Pharmaceutical Company Ltd.
  • Pfizer
  • Johnson & Johnson Services Inc.
  • Sanofi S.A.
  • Novartis AG
  • Boehringer Ingelheim International GmbH
  • GlaxoSmithKline PLC
  • Mylan
  • UPM Pharmaceuticals

Segments Covered in the Report

By Product Type

  • Vitamin and Dietary Supplements
  • Cough & Cold Products
  • Analgesics
  • Gastrointestinal Products
  • Sleep Aids
  • Otic Products
  • Wart Removers
  • Mouth Care Products
  • Ophthalmic Products
  • Botanicals
  • Antacids
  • Smoking Cessation Products
  • Feminine Care
  • Others

By Dosage Form

  • Tablets
  • Hard Capsules
  • Powders
  • Ointments
  • Soft Capsules
  • Liquids
  • Others

By Route of Administration

  • Oral
  • Parenteral
  • Topical
  • Others

By Distribution Channel

  • Drug Stores & Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on U.S. Over the Counter (OTC) Drugs Market 

5.1. COVID-19 Landscape: U.S. Over the Counter (OTC) Drugs Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. U.S. Over the Counter (OTC) Drugs Market, By Product Type

8.1. U.S. Over the Counter (OTC) Drugs Market Revenue and Volume Forecast, by Product Type, 2024-2033

8.1.1. Vitamin and Dietary Supplements

8.1.1.1. Market Revenue and Volume Forecast (2021-2033)

8.1.2. Cough & Cold Products

8.1.2.1. Market Revenue and Volume Forecast (2021-2033)

8.1.3. Analgesics

8.1.3.1. Market Revenue and Volume Forecast (2021-2033)

8.1.4. Gastrointestinal Products

8.1.4.1. Market Revenue and Volume Forecast (2021-2033)

8.1.5. Sleep Aids

8.1.5.1. Market Revenue and Volume Forecast (2021-2033)

8.1.6. Otic Products

8.1.6.1. Market Revenue and Volume Forecast (2021-2033)

8.1.7. Wart Removers

8.1.7.1. Market Revenue and Volume Forecast (2021-2033)

8.1.8. Mouth Care Products

8.1.8.1. Market Revenue and Volume Forecast (2021-2033)

8.1.9. Ophthalmic Products

8.1.9.1. Market Revenue and Volume Forecast (2021-2033)

8.1.10. Botanicals

8.1.10.1. Market Revenue and Volume Forecast (2021-2033)

8.1.11. Antacids

8.1.11.1. Market Revenue and Volume Forecast (2021-2033)

8.1.12. Smoking Cessation Products

8.1.12.1. Market Revenue and Volume Forecast (2021-2033)

8.1.13. Feminine Care

8.1.13.1. Market Revenue and Volume Forecast (2021-2033)

8.1.14. Others

8.1.14.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 9. U.S. Over the Counter (OTC) Drugs Market, By Dosage Form

9.1. U.S. Over the Counter (OTC) Drugs Market Revenue and Volume Forecast, by Dosage Form, 2024-2033

9.1.1. Tablets

9.1.1.1. Market Revenue and Volume Forecast (2021-2033)

9.1.2. Hard Capsules

9.1.2.1. Market Revenue and Volume Forecast (2021-2033)

9.1.3. Powders

9.1.3.1. Market Revenue and Volume Forecast (2021-2033)

9.1.4. Ointments

9.1.4.1. Market Revenue and Volume Forecast (2021-2033)

9.1.5. Soft Capsules

9.1.5.1. Market Revenue and Volume Forecast (2021-2033)

9.1.6. Liquids

9.1.6.1. Market Revenue and Volume Forecast (2021-2033)

9.1.7. Others

9.1.7.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 10. U.S. Over the Counter (OTC) Drugs Market, By Route of Administration 

10.1. U.S. Over the Counter (OTC) Drugs Market Revenue and Volume Forecast, by Route of Administration, 2024-2033

10.1.1. Oral

10.1.1.1. Market Revenue and Volume Forecast (2021-2033)

10.1.2. Parenteral

10.1.2.1. Market Revenue and Volume Forecast (2021-2033)

10.1.3. Topical

10.1.3.1. Market Revenue and Volume Forecast (2021-2033)

10.1.4. Others

10.1.4.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 11. U.S. Over the Counter (OTC) Drugs Market, By Distribution Channel 

11.1. U.S. Over the Counter (OTC) Drugs Market Revenue and Volume Forecast, by Distribution Channel, 2024-2033

11.1.1. Drug Stores & Retail Pharmacies

11.1.1.1. Market Revenue and Volume Forecast (2021-2033)

11.1.2. Hospital Pharmacies

11.1.2.1. Market Revenue and Volume Forecast (2021-2033)

11.1.3. Online Pharmacies

11.1.3.1. Market Revenue and Volume Forecast (2021-2033)

Chapter 12. U.S. Over the Counter (OTC) Drugs Market and Trend Forecast

12.1. U.S.

12.1.1. Market Revenue and Volume Forecast, by Product Type (2021-2033)

12.1.2. Market Revenue and Volume Forecast, by Dosage Form (2021-2033)

12.1.3. Market Revenue and Volume Forecast, by Route of Administration (2021-2033)

12.1.4. Market Revenue and Volume Forecast, by Distribution Channel (2021-2033)

Chapter 13. Company Profiles

13.1. Bayer AG

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Takeda Pharmaceutical Company Ltd.

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Pfizer

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Johnson & Johnson Services Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Sanofi S.A.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Novartis AG

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Boehringer Ingelheim International GmbH

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. GlaxoSmithKline PLC

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Mylan

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. UPM Pharmaceuticals

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.autoindustrybulletin.com/

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *